Thomas Jaki
OTH Regensburg(DE)University of Cambridge(GB)MRC Biostatistics Unit(GB)University of Regensburg(DE)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Optimal Experimental Design Methods, Health Systems, Economic Evaluations, Quality of Life, COVID-19 Clinical Research Studies, Advanced Causal Inference Techniques
Most-Cited Works
- → Dexamethasone in Hospitalized Patients with Covid-19.(2020)8,025 cited
- → A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19(2020)5,500 cited
- → Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial(2020)3,652 cited
- → Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report(2020)843 cited
- → Adaptive designs in clinical trials: why use them, and how to run and report them(2018)805 cited
- → Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial(2020)743 cited